Hypoxia down-regulates sFlt-1 (sVEGFR-1) expression in human microvascular endothelial cells by a mechanism involving mRNA alternative processing

Biochemical Journal

Volumn 436, Issue 2, 2011, Pages 399-407

  Ikeda, Takayuki ^a   Sun, Li ^a,b   Tsuruoka, Naoki ^a   Ishigaki, Yasuhito ^a   Yoshitomi, Yasuo ^a   Yoshitake, Yoshino ^a   Yonekura, Hideto ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Hypoxia; mRNA 3 end processing; Soluble Flt 1; Vascular endothelial cell; Vascular endothelial growth factor (VEGF)

Indexed keywords

CIS ACTING ELEMENT; LENTIVIRUS VECTOR; MESSENGER RNA; OXYGEN; POLYADENYLIC ACID; RNA; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ARTICLE; CELL HYPOXIA; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRON; MUTAGENESIS; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA PROCESSING;

ALTERNATIVE SPLICING; BASE SEQUENCE; CELL HYPOXIA; CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIAL CELLS; HUMANS; MICROCIRCULATION; MOLECULAR SEQUENCE DATA; RNA 3' END PROCESSING; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 79956028094     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20101490     Document Type: Article

References (31)

1. Griffioen, A. W. and Molema, G. (2000) Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev. 52, 237-268
2. Hanahan, D. and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364 (Pubitemid 26272076)
3. Nomura, M., Yamagishi, S., Harada, S., Hayashi, Y., Yamashima, T., Yamashita, J. and Yamamoto, H. (1995) Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J. Biol. Chem. 270, 28316-28324
4. Yonekura, H., Sakurai, S., Liu, X., Migita, H., Wang, H., Yamagishi, S., Nomura, M., Abedin, M. J., Unoki, H., Yamamoto, Y. and Yamamoto, H. (1999) Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis. J. Biol. Chem. 274, 35172-35178
5. Wu, P., Yonekura, H., Li, H., Nozaki, I., Tomono, Y., Naito, I., Ninomiya, Y. and Yamamoto, H. (2001) Hypoxia down-regulates endostatin production by human microvascular endothelial cells and pericytes. Biochem. Biophys. Res. Commun. 288, 1149-1154
6. Li, H., Yonekura, H., Kim, C. H., Sakurai, S., Yamamoto, Y., Takiya, T., Futo, S., Watanabe, T. and Yamamoto, H. (2004) Possible participation of pICln in the regulation of angiogenesis through alternative splicing of vascular endothelial growth factor receptor mRNAs. Endothelium 11, 293-300 (Pubitemid 40123398)
7. Kendall, R. L. and Thomas, K. A. (1993) inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. U.S.A. 90, 10705-10709
8. Waltenberger, J., Welsh, L. C., Siegbahn, A., Shibuya, M. and Heldin, C. H. (1994) Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269, 26988-26995
9. Ambati, B. K., Nozaki, M., Singh, N., Takeda, A., Jani, P. D., Suthar, T., Albuquerque, R. J. C., Richter, E., Sakurai, E., Newcomb, M. T. et al. (2006) Corneal avascularity is due to soluble VEGF receptor-1. Nature 443, 993-997 (Pubitemid 44646176)
10. Chappell, J. C., Taylor, S. M., Ferrara, N. and Bautch, V. L. (2009) Local guidance of emerging vessel sprouts requires soluble Flt-1. Dev. Cell 17, 377-386
11. Maynard, S. E., Min, J. Y., Merchan, J., Lim, K. H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E. et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649-658
12. Goldman, C. K., Kendall, R. L., Cabrera, G., Soroceanu, L., Heike, Y., Gillespie, G. Y., Siegal, G. P., Mao, X., Bett, A. J., Huckle, W. R. et al. (1998) Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc. Natl. Acad. Sci. U.S.A. 95, 8795-8800
13. Shweiki, D., Itin, A., Soffer, D. and Keshet, E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845
14. Xiong, Y., Liebermann, D. A., Tront, J. S., Holtzman, E. J., Huang, Y., Hoffman, B. and Geifman-Holtzman, O. (2009) Gadd45a stress signaling regulates sFlt-1 expression in preeclampsia. J. Cell. Physiol. 220, 632-639
15. Nagamatsu, T., Fujii, T., Kusumi, M., Zou, L., Yamashita, T., Osuga, Y., Momoeda, M., Kozuma, S. and Taketani, Y. (2004) Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 145, 4838-4845 (Pubitemid 39551100)
16. Munaut, C., Lorquet, S., Pequeux, C., Blacher, S., Berndt, S., Frankenne, F. and Foidart, J. M. (2008) Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast. Hum. Reprod. 23, 1407-1415
17. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
18. Fong, G. H. (2008) Mechanisms of adaptive angiogenesis to tissue hypoxia. Angiogenesis 11, 121-140
19. 2-regulated prolyl hydroxylation. Science 292, 468-472
20. Roeckl, W., Hecht, D., Sztajer, H., Waltenberger, J., Yayon, A. and Weich, H. A. (1998) Differential binding characteristics and cellular inhibition by soluble VEGF receptor 1 and 2. Exp. Cell Res. 241, 161-170
21. Bourgeois, C. F., Lejeune, F. and Stevenin, J. (2004) Broad specificity of SR (serine/arginine) proteins in the regulation of alternative splicing of pre-messenger RNA. Prog. Nucleic Acid Res. Mol. Biol. 78, 37-88
22. Barreau, A., Paillard, L. and Osborne, H. B. (2005) AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 33, 7138-7150
23. Mandel, C. R., Bai, Y. and Tong, L. (2008) Protein factors in pre-mRNA 3́-end processing. Cell. Mol. Life Sci. 65, 1099-1122
24. Chennathukuzhi, V. M., Lefrancois, S., Morales, C. R., Syed, V. and Hecht, N. B. (2001) Elevated levels of the polyadenylation factor CstF 64 enhance formation of the 1kB testis brain RNA-binding protein (TB-RBP) mRNA in male germ cells. Mol. Reprod. Dev. 58, 460-469
25. Shell, S. A., Hesse, C., Morris, Jr, S. M. and Milcarek, C. (2005) Elevated levels of the 64-kDa cleavage stimulatory factor (CstF-64) in lipopolysaccharide-stimulated macrophages influence gene expression and induce alternative poly(A) site selection. J. Biol. Chem. 280, 39950-39961
26. Kubo, T., Wada, T., Yamaguchi, Y., Shimizu, A. and Handa, H. (2006) Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3́-UTRs. Nucleic Acids Res. 34, 6264-6271 (Pubitemid 44942747)
27. Wu, F. T. H., Stefanini, M. O., Gabhann, F. M., Kontos, C. D., Annex, B. H. and Popel, A. S. (2010) A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. J. Cell. Mol. Med. 14, 528-552
28. Gerger, H. P., Condorelli, F., Park, J. and Ferrara, N. (1997) Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. J. Biol. Chem. 272, 23659-23667
29. Tscheudschilsuren, G., Aust, G., Nieber, K., Schilling, N. and Spanel-Borowski, K. (2002) Microvascular endothelial cells differ in basal and hypoxia-regulated expression of angiogenic factors and their receptors. Microvasc. Res. 63, 243-251
30. Brylla, E., Tscheudschilsuren, G., Santos, A. N., Nieber, K., Borowski, K. S. and Aust, G. (2003) Differences between retinal and choroidal microvascular endothelial cells (MVECs) under normal and hypoxia conditions. Exp. Eye Res. 77, 527-535
31. Olsson, A. K., Dimberg, A., Kreuger, J. and Claesson-Welsh, L. (2006) VEGF receptor signalling: in control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359-371